L
Lucira Health
IVD, Consumer Health, Disposable Testing
About Lucira Health
Lucira Health is a biotechnology company specializing in the development of at-home diagnostic tests. The company primarily serves individual consumers who require quick and reliable health diagnostics, particularly in the context of infectious diseases. Operating in the healthcare and biotechnology market, Lucira Health's core product is a single-use, disposable COVID-19 test kit that provides results within 30 minutes. This test is designed to detect active shedding of the SARS-CoV-2 virus, which is crucial for determining contagiousness and taking necessary precautions. The business model revolves around direct-to-consumer sales, aiming to make at-home testing simple, affordable, and accessible. Revenue is generated through the sale of these diagnostic kits. Lucira Health's technology, which has been in development for over five years, is also adaptable for detecting other viruses, such as influenza, making it versatile for future applications.
Source: Dealroom company dataAt a glance
- Founded
- 2013
- Headquarters
- Emeryville, United States
- Sector
- Health Tech & Medtech
Latest news
Press, funding announcements and product moves mentioning Lucira Health.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
Y Combinator
Seraph Group
Series A6 investors entered at this stage
Eclipse Ventures
Hedgewood
OS Fund
11.2 Capital
Sunstone Management
ShangBay Capital
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Lucira Health on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Lucira Health on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.